Next 10 |
Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT) PR Newswire Partnership enables Vapotherm to build a robust and secure solution 80% faster than the standard development timeline to meet data visualization and de...
Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE PR Newswire EXETER, N.H. , March 15, 2024 /PRNewswire/ -- Vapotherm, Inc., (OTCQX: VAPO), ("Vapotherm" or the "Company") today announced the debut of its Access365™ Home Ventilation Soluti...
Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherm's High Velocity Therapy effectively treats moderate-severe acute exacerbations of COPD, while improving patien...
Vapotherm's HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South America's Largest Health Care Market PR Newswire EXETER, N.H. , Feb. 29, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), a global medical technology c...
Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results PR Newswire EXETER, N.H. , Feb. 22, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), today announced fourth quarter and fiscal year 2023 financial results a...
2023-12-18 08:26:30 ET Losers: Chanson International Holding ( CHSN ) -88% . Inno Holdings ( INHD ) -85% . Maison Solutions ( MSS ) -84% issues statement regarding short attack on its securities . Aadi Bioscience ( AADI ) -56% . Sing...
NEW YORK, Dec. 15, 2023 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced Vapotherm, Inc. (OTCQX: VAPO), a global medical technology company specializing in the development and commercializ...
2023-12-15 04:56:31 ET More on Vapotherm Vapotherm, Inc. (VAPO) Q3 2023 Earnings Call Transcript Vapotherm slips on announcing voluntary delisting from NYSE to OTCQX Marketplace Vapotherm high velocity therapy outperforms in children with asthma Seeking Alpha...
Vapotherm Announces Suspension of NYSE Listing Common Stock Expected to Begin Trading Promptly on OTCQX PR Newswire EXETER, N.H. , Dec. 14, 2023 /PRNewswire/ -- Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company") today announced it has received notice th...
2023-12-12 12:30:31 ET Gainers: C4 Therapeutics ( CCCC ) +85% . Aditxt ( ADTX ) +71% . Icosavax ( ICVX ) +48% . IN8bio ( INAB ) +31% . Petros Pharmaceuticals ( PTPI ) +31% . Clean Earth Acquisitions Corp ( CLIN ) +26% ...
News, Short Squeeze, Breakout and More Instantly...
Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT) PR Newswire Partnership enables Vapotherm to build a robust and secure solution 80% faster than the standard development timeline to meet data visualization and de...
Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE PR Newswire EXETER, N.H. , March 15, 2024 /PRNewswire/ -- Vapotherm, Inc., (OTCQX: VAPO), ("Vapotherm" or the "Company") today announced the debut of its Access365™ Home Ventilation Soluti...
Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherm's High Velocity Therapy effectively treats moderate-severe acute exacerbations of COPD, while improving patien...